In our Regulatory Snapshot, when we say a country treats Medicinal Cannabis as restricted, it means that products like cannabidiol (CBD) oils are only allowed under formal medicine registration rules. This does not exclude other interpretations, where the same CBD oil may be seen as a herbal medicine, supplement, or even a superfood. In many countries, this remains a “grey area” — a space where entrepreneurs must actively engage and help shape the path forward.
What you'll learn
Table of contents
Switzerland Introduction
Switzerland combines a liberal hemp/CBD stance with measured reforms for cannabis. Medical cannabis was streamlined in 2022, ending the exceptional-licence regime and allowing prescription-based access. Adult-use remains illegal nationwide, but multiple city pilot projects are testing regulated sales. A distinctive feature is the ≤1% THC threshold for hemp, enabling a robust CBD market. Psychedelics remain controlled, with limited research or compassionate-use exemptions.
---
Cannabis & Wellness Regulation Overview
Recreational Cannabis (Adult Use)
Status: Not nationally legal; pilot projects active.
- The federal framework authorizes time-bound pilot trials where adults can purchase regulated cannabis through selected pharmacies/points of sale in participating cities (e.g., Zurich, Basel, Bern, Geneva).
- Outside pilots, possession/use is generally illegal; small-quantity possession typically triggers administrative fines, not a criminal record (law-enforcement practice varies by canton).
- Advertising is prohibited; plain packaging and strong age controls in pilots.
Medical Cannabis
Status: Prescription-based since 2022 reform.
- Physicians can prescribe cannabis medicines without the former exceptional-licence process.
- Products must comply with Swissmedic pharmaceutical standards (GMP/GDP; THC/CBD specs; contaminants testing).
- Domestic production and imports (EU-GMP) are allowed under licence; pharmacy dispensing is standard.
- Promotion to the public is not allowed; scientific/healthcare communications only.
Hemp Definition & Industrial Use
Status: Liberal Swiss threshold.
- Hemp and hemp products with ≤1% THC are not narcotics under Swiss law.
- Fibre, seeds, hemp seed oil, and low-THC “CBD cannabis” (e.g., smokable) are lawful if they meet the ≤1% THC limit and other product-category rules (tobacco substitutes, consumer products, etc.).
CBD Products
Status: Broadly legal under ≤1% THC; category-specific rules.
- CBD is not a narcotic if THC ≤1%.
- Food/supplements containing CBD fall under Novel Food—need authorization before marketing.
- Cosmetics with CBD are permitted if safe and compliant (see next section).
- Smokable CBD products are regulated like tobacco substitutes (age restrictions, warnings).
- Therapeutic claims trigger medicinal classification.
Cosmetics & Artisanal Products
Status: Allowed with constraints.
- CBD may be used in cosmetics if non-narcotic (THC ≤1%), with a safety assessment, compliant INCI, and notification/market-surveillance duties.
- THC must remain ≤1% in trace terms; functional/medicinal claims are not allowed for cosmetics.
- GMP for cosmetics and standard labelling in the local language(s) apply.
Functional Mushrooms & Adaptogens
Status: Permitted under food law.
- Reishi, lion’s mane, cordyceps, chaga, etc. are sold as foods or supplements.
- Claims must follow Swiss/EU nutrition & health-claims principles (no disease claims).
- Certain novel extracts may require Novel Food assessment/authorization.
Psilocybin / Psychedelics
Status: Controlled substances.
- Psilocybin remains prohibited for general use.
- Research and compassionate-use exceptions can be granted on a case-by-case basis under strict oversight.
- No retail or wellness use is permitted.
---
Operating Guidance (Hemp Vegan)
Wellness-Driven Coffee & Retail
Switzerland is prime for a compliance-first wellness model:
- Choose your space: cafés + wellness retail emphasizing hemp seed foods, functional mushrooms, adaptogens, teas.
- Plug into the ecosystem: partner pharmacies for medical education, and vetted suppliers for EU-GMP medical cannabis and CBD products.
- Grow with support: SOPs for Novel Food assessments, pilot-project guardrails, and canton-specific compliance.
Clinical Tools & AI
- AI-assisted prescribing support (indications, dosing, interactions) under Swissmedic rules.
- Compliance prompts (≤1% THC checks, pilot-project restrictions, label wording).
- Bilingual content (DE/FR/IT/EN) for patient literacy and clinician guidance.
---
Marketing, Claims & Compliance
Advertising & Claims
- Cannabis (medical/pilot): zero lifestyle advertising; education-only communications.
- CBD/hemp: no medicinal claims; observe age-gating for smokables; clear warnings where applicable.
- Supplements: structure/function style; only authorized health claims.
Packaging & Labeling
- Medical: pharma-grade labelling, batch/expiry, cannabinoid content, leaflet; pharmacy dispensing.
- CBD smokables/tobacco substitutes: health warnings, age restriction, product testing documentation.
- Foods/supplements: ingredients, allergens, nutrition, operator details; Novel Food authorization if CBD is used.
- Cosmetics: INCI list, RP details, safety dossier, batch, shelf-life, instructions.
---
Taxes, Import & Duties
- VAT: 7.7% (standard).
- Medical cannabis: import/export subject to Swissmedic licensing and narcotics/medicines controls.
- CBD smokables: excise/tobacco-substitute rules may apply; check cantonal praxis.
- Foods/cosmetics: customs classification + product-category compliance at import.
---
Risks & Practical Notes
- Recreational: only via pilot trials; no national retail yet.
- Medical: robust but pharmaceutical—compliance and supply documentation are decisive.
- CBD foods: Novel Food hurdle; plan timelines and evidence.
- Strategy: lead with hemp seed foods, functional mushrooms, cosmetics with CBD (no THC >1%, no medical claims); develop medical education and pilot-city partnerships.
---
FAQ (Hemp Vegan)
How does Hemp Vegan support operations in Switzerland?
We design a compliance-first roadmap: CBD (non-food) channels, cosmetics dossiers, medical education with pharmacies, and readiness for pilot-project participation.
Can I sell CBD edibles freely?
Não. CBD em alimentos requer autorização Novel Food antes de comercializar.
Are CBD cosmetics allowed?
Sim, se THC ≤1%, segurança comprovada e sem claims terapêuticas—seguindo dossiê/safety e rotulagem.
Can I join the adult-use pilots?
Somente mediante parcerias aprovadas dentro de projetos municipais, com requisitos de pesquisa e compliance estritos.
---
Sources & Review Log
_Last reviewed_: 2025-08-23
- Medical cannabis reform (2022) — prescription model under Swissmedic
- Federal pilot trials (adult use) — city-level regulated studies framework
- Hemp/CBD ≤1% THC — non-narcotic classification in Swiss law
- Novel Food/CBD food — authorization requirement for edibles
- Cosmetics — CBD permitted with safety; THC must remain ≤1%
